Catabasis Pharma (CATB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CATB | GRCE | LTRN | ||
| Company | Catabasis Pharma | Grace Therapeutics Inc | Lantern Pharma Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 9.21 | 2.09 | 2.73 | ||
| High | 9.21 | 2.18 | 2.88 | ||
| Low | 8.46 | 2.07 | 2.65 | ||
| Last | 8.54 | 2.18 | 2.75 | ||
| Change | -0.64 | +0.10 | +0.14 | ||
| Percent Change | -6.97% | +4.81% | +5.36% | ||
| Volume | 98,800 | 100,500 | 82,900 | ||
| 20-Day Average Volume | 395,311 | 221,295 | 128,655 | ||
| Previous | 9.18 | 2.08 | 2.61 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 8.72 | 2.33 | 2.92 | ||
| 20-Day Raw Stochastic | 56.46% | 46.48% | 18.90% | ||
| 20-Day Relative Strength | 43.24 | 41.71 | 42.97 | ||
| Weighted Alpha | -50.43 | +8.72 | -44.78 | ||
| Today's Opinion | 88% Sell | 100% Sell | 40% Sell | ||
| Yesterday's Opinion | 72% Sell | 96% Sell | 40% Sell | ||
| Last Month's Opinion | 100% Sell | 56% Sell | 80% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -14.34% since 08/31/21 | -3.11% since 07/28/26 | +5.77% since 07/28/26 | ||
| Low | 8.46 on 09/08/21 | 1.85 on 07/29/26 | 2.51 on 07/30/26 | ||
| High | 10.26 on 09/02/21 | 2.25 on 07/29/26 | 2.88 on 08/04/26 | ||
| 1-Month | |||||
| %Chg | -8.17% since 08/06/21 | -8.02% since 07/02/26 | -30.73% since 07/02/26 | ||
| Low | 6.31 on 08/20/21 | 1.85 on 07/29/26 | 2.51 on 07/30/26 | ||
| High | 10.26 on 09/02/21 | 2.58 on 07/07/26 | 4.18 on 07/06/26 | ||
| 3-Month | |||||
| %Chg | -34.10% since 06/08/21 | -7.63% since 05/04/26 | +23.32% since 05/04/26 | ||
| Low | 6.31 on 08/20/21 | 1.85 on 07/29/26 | 2.00 on 05/12/26 | ||
| High | 15.72 on 06/16/21 | 2.71 on 06/01/26 | 4.34 on 07/01/26 | ||
| 6-Month | |||||
| %Chg | -50.23% since 03/08/21 | -40.76% since 02/04/26 | -6.78% since 02/04/26 | ||
| Low | 6.31 on 08/20/21 | 1.79 on 04/23/26 | 1.11 on 03/27/26 | ||
| High | 22.01 on 03/18/21 | 5.18 on 04/02/26 | 4.34 on 07/01/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 33,337 | 33,850 | 33,301 | ||
| Shares Outstanding, K | 3,904 | 16,274 | 12,759 | ||
| Annual Sales, $M | 0 | 0 | 0 | ||
| Annual Net Income, $M | -37,300,000 | -7,790,000 | -17,120,000 | ||
| Last Qtr Sales, $M | 0 | 0 | 0 | ||
| Last Qtr Income, $M | -7,470,000 | -1,180,000 | -3,330,000 | ||
| 60-Month Beta | 1.66 | 0.39 | 2.35 | ||
| Per-Share Information | |||||
| Most Recent Earnings | N/A | -0.07 on 06/18/26 | -0.30 on 05/15/26 | ||
| Latest Earnings Date | 11/11/21 | 08/11/26 | 08/12/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividend Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||